Skip to content
lifestyle.independent.mk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BeyondSpring, Inc.
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
September 30, 2026
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
August 14, 2026
BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting
May 24, 2026
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
May 23, 2026
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
April 22, 2026
BeyondSpring Files 2025 Annual Report on Form 10-K
March 25, 2026
BeyondSpring Reports 2025 Year-End Financial Results
March 25, 2026
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
February 12, 2026